These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 35016917)

  • 1. RNA interference (RNAi)-based plasmonic nanomaterials for cancer diagnosis and therapy.
    Yoon J; Shin M; Lee JY; Lee SN; Choi JH; Choi JW
    J Control Release; 2022 Feb; 342():228-240. PubMed ID: 35016917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNA interference and cancer therapy.
    Wang Z; Rao DD; Senzer N; Nemunaitis J
    Pharm Res; 2011 Dec; 28(12):2983-95. PubMed ID: 22009588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNAi-based therapeutics and tumor targeted delivery in cancer.
    Kara G; Calin GA; Ozpolat B
    Adv Drug Deliv Rev; 2022 Mar; 182():114113. PubMed ID: 35063535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA interference-based therapy and its delivery systems.
    Chen X; Mangala LS; Rodriguez-Aguayo C; Kong X; Lopez-Berestein G; Sood AK
    Cancer Metastasis Rev; 2018 Mar; 37(1):107-124. PubMed ID: 29243000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noncoding RNA for Cancer Gene Therapy.
    Zhong X; Zhang D; Xiong M; Zhang L
    Recent Results Cancer Res; 2016; 209():51-60. PubMed ID: 28101687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional nanostructures for effective delivery of small interfering RNA therapeutics.
    Hong CA; Nam YS
    Theranostics; 2014; 4(12):1211-32. PubMed ID: 25285170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanocarrier mediated delivery of siRNA/miRNA in combination with chemotherapeutic agents for cancer therapy: current progress and advances.
    Gandhi NS; Tekade RK; Chougule MB
    J Control Release; 2014 Nov; 194():238-56. PubMed ID: 25204288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic delivery of small RNA using lipid nanoparticles.
    Asai T; Oku N
    Biol Pharm Bull; 2014; 37(2):201-5. PubMed ID: 24492716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanoparticle-based delivery of small interfering RNA: challenges for cancer therapy.
    Miele E; Spinelli GP; Miele E; Di Fabrizio E; Ferretti E; Tomao S; Gulino A
    Int J Nanomedicine; 2012; 7():3637-57. PubMed ID: 22915840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNA interference (RNAi)-based therapeutics for treatment of rare neurologic diseases.
    Germain ND; Chung WK; Sarmiere PD
    Mol Aspects Med; 2023 Jun; 91():101148. PubMed ID: 36257857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic siRNA: principles, challenges, and strategies.
    Gavrilov K; Saltzman WM
    Yale J Biol Med; 2012 Jun; 85(2):187-200. PubMed ID: 22737048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo application of RNA interference: from functional genomics to therapeutics.
    Lu PY; Xie F; Woodle MC
    Adv Genet; 2005; 54():117-42. PubMed ID: 16096010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Review of pH-Responsive Organic-Inorganic Hybrid Nanoparticles for RNAi-Based Therapeutics.
    Wang L; Yan Y
    Macromol Biosci; 2021 Sep; 21(9):e2100183. PubMed ID: 34160896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cationic liquid crystalline nanoparticles for the delivery of synthetic RNAi-based therapeutics.
    Gentile E; Oba T; Lin J; Shao R; Meng F; Cao X; Lin HY; Mourad M; Pataer A; Baladandayuthapani V; Cai D; Roth JA; Ji L
    Oncotarget; 2017 Jul; 8(29):48222-48239. PubMed ID: 28637023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNA Interference-Based Cancer Drugs: The Roadblocks, and the "Delivery" of the Promise.
    Das M; Musetti S; Huang L
    Nucleic Acid Ther; 2019 Apr; 29(2):61-66. PubMed ID: 30562145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effective tools for RNA-derived therapeutics: siRNA interference or miRNA mimicry.
    Wang P; Zhou Y; Richards AM
    Theranostics; 2021; 11(18):8771-8796. PubMed ID: 34522211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNAi-based drug discovery and its application to therapeutics.
    Hokaiwado N; Takeshita F; Banas A; Ochiya T
    IDrugs; 2008 Apr; 11(4):274-8. PubMed ID: 18379962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delivery of RNAi-Based Therapeutics for Bone Regeneration.
    Malcolm DW; Wang Y; Overby C; Newman M; Benoit DSW
    Curr Osteoporos Rep; 2020 Jun; 18(3):312-324. PubMed ID: 32394316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nano-based delivery of RNAi in cancer therapy.
    Xin Y; Huang M; Guo WW; Huang Q; Zhang LZ; Jiang G
    Mol Cancer; 2017 Jul; 16(1):134. PubMed ID: 28754120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNA-based Therapeutics: Past, Present and Future Prospects, Challenges in Cancer Treatment.
    Goel A; Rastogi A; Jain M; Niveriya K
    Curr Pharm Biotechnol; 2024; 25(16):2125-2137. PubMed ID: 38347795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.